Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Questionnaire
2.3. Ethical Approval
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Nicola, M.; Alsafi, Z.; Sohrabi, C.; Kerwan, A.; Al-Jabir, A.; Iosifidis, C.; Agha, M.; Agha, R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 2020, 78, 185–193. [Google Scholar] [CrossRef]
- United Nations Development Program. COVID-19 Pandemic Humanity Needs Leadership and Solidarity to Defeat COVID-19 Egypt: United Nations Development Programme. 2020. Available online: https://www.eg.undp.org/content/egypt/en/home/coronavirus.html (accessed on 25 March 2021).
- Rawat, K.; Kumari, P.; Saha, L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur. J. Pharmacol. 2021, 892, 173751. [Google Scholar] [CrossRef]
- MacDonald, N.E. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Yuan, P.; Ai, P.; Liu, Y.; Ai, Z.; Wang, Y.; Cao, W.; Xia, X.; Zheng, J.C. Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. medRxiv 2020, 11.03.20224998. [Google Scholar] [CrossRef]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, B.; et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021, 384, 403–416. [Google Scholar] [CrossRef]
- Voysey, M.; Clemens, S.A.C.; Madhi, S.A.; Weckx, L.Y.; Folegatti, P.M.; Aley, P.K.; Angus, B.; Baillie, V.L.; Barnabas, S.L.; Bhorat, Q.E.; et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021, 397, 99–111. [Google Scholar] [CrossRef]
- Al-Qerem, W.A.; Jarab, A.S. COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population. Front. Public Health 2021, 9, 632914. [Google Scholar] [CrossRef] [PubMed]
- Daley, M.F.; Narwaney, K.J.; Shoup, J.A.; Wagner, N.M.; Glanz, J.M. Addressing Parents’ Vaccine Concerns: A Randomized Trial of a Social Media Intervention. Am. J. Prev. Med. 2018, 55, 44–54. [Google Scholar] [CrossRef]
- Arede, M.; Bravo-Araya, M.; Bouchard, É.; Gill, G.S.; Plajer, V.; Shehraj, A.; Shuaib, Y.A. Combating Vaccine Hesitancy: Teaching the Next Generation to Navigate Through the Post Truth Era. Front. Public Health 2018, 6, 381. [Google Scholar] [CrossRef] [Green Version]
- Worldometers. Coronavirus Cases in Jordan. Dadax Ltd. Available online: https://www.worldometers.info/coronavirus/country/jordan/ (accessed on 26 March 2021).
- Wagner, A.L.; Masters, N.B.; Domek, G.J.; Mathew, J.L.; Sun, X.; Asturias, E.J.; Ren, J.; Huang, Z.; Contreras-Roldan, I.L.; Gebremeskel, B.; et al. Comparisons of Vaccine Hesitancy across Five Low- and Middle-Income Countries. Vaccines 2019, 7, 155. [Google Scholar] [CrossRef] [Green Version]
- Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef]
- Karafillakis, E.; Larson, H.J. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine 2017, 35, 4840–4850. [Google Scholar] [CrossRef] [PubMed]
- Jordan University Hospital. Jordan University Hospital Annual Report 2019. 2019. Available online: http://hospital.ju.edu.jo/AnnualReports/Forms/All_Reports.aspx (accessed on 26 March 2021).
- Australian Bureau of Statistics: Sample Size Calculator. Available online: https://www.abs.gov.au/websitedbs/d3310114.nsf/home/sample+size+calculator (accessed on 2 May 2021).
- Jordanian Ministry of Health. COVID-19 Vaccination Platform: MOH. 2021. Available online: https://vaccine.jo/cvms/ (accessed on 26 March 2021).
- Omari, R. Jordan Begins COVID-19 Vaccination Drive as Physician, 87, Gets First Jab Jeddah, 21433, Saudi Arabia: Arab News. 2021. Available online: https://www.arabnews.com/node/1791926/middle-east (accessed on 13 January 2021).
- Boodoosingh, R.; Olayemi, L.O.; Sam, F.A. COVID-19 vaccines: Getting Anti-vaxxers involved in the discussion. World Dev. 2020, 136, 105177. [Google Scholar] [CrossRef]
- Tsang, S.; Royse, C.F.; Terkawi, A.S. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J. Anaesth. 2017, 11, S80–S89. [Google Scholar] [CrossRef]
- Long, Q.X.; Liu, B.Z.; Deng, H.J.; Wu, G.C.; Deng, K.; Chen, Y.K.; Liao, P.; Qiu, J.-F.; Lin, Y.; Cai, X.-F.; et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 2020, 26, 845–848. [Google Scholar] [CrossRef]
- Xiao, A.T.; Gao, C.; Zhang, S. Profile of specific antibodies to SARS-CoV-2: The first report. J. Infect. 2020, 81, 147–178. [Google Scholar] [CrossRef]
- Du, Z.; Zhu, F.; Guo, F.; Yang, B.; Wang, T. Detection of antibodies against SARS-CoV-2 in patients with COVID-19. J. Med. Virol. 2020, 92, 1735–1738. [Google Scholar] [CrossRef] [Green Version]
- Larson, H.J.; De Figueiredo, A.; Xiahong, Z.; Schulz, W.S.; Verger, P.; Johnston, I.G.; Cook, A.R.; Jones, N.S. The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey. EBioMedicine 2016, 12, 295–301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wellcome Trust. Wellcome Global Monitor: How Does the World Feel about Science and Health. 2019. Available online: https://wellcome.org/sites/default/files/wellcome-global-monitor-2018.pdf (accessed on 9 February 2021).
- Iyengar, K.P.; Ish, P.; Upadhyaya, G.K.; Malhotra, N.; Vaishya, R.; Jain, V.K. COVID-19 and mortality in doctors. Diabetes Metab. Syndr. 2020, 14, 1743–1746. [Google Scholar] [CrossRef] [PubMed]
- Parikh, P.A.; Shah, B.V.; Phatak, A.G.; Vadnerkar, A.C.; Uttekar, S.; Thacker, N.; Nimbalkar, S.M. COVID-19 Pandemic: Knowledge and Perceptions of the Public and Healthcare Professionals. Cureus 2020, 12, e8144. [Google Scholar] [CrossRef] [PubMed]
- Suleiman, A.; Bsisu, I.; Guzu, H.; Santarisi, A.; Alsatari, M.; Abbad, A.; Jaber, A.; Harb, T.; Abuhejleh, A.; Nadi, N.; et al. Preparedness of Frontline Doctors in Jordan Healthcare Facilities to COVID-19 Outbreak. Int. J. Environ. Res. Public Health 2020, 17, 3181. [Google Scholar] [CrossRef] [PubMed]
- Wang, P.-W.; Lu, W.-H.; Ko, N.-Y.; Chen, Y.-L.; Li, D.-J.; Chang, Y.-P.; Yen, C.-F. COVID-19-related information sources and the relationship with confidence in people coping with COVID-19: Facebook survey study in Taiwan. J. Med. Internet Res. 2020, 22, e20021. [Google Scholar] [CrossRef] [PubMed]
- Lai, J.; Ma, S.; Wang, Y.; Cai, Z.; Hu, J.; Wei, N.; Wu, J.; Du, H.; Chen, T.; Li, R.; et al. Factors Associated with Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw. Open 2020, 3, e203976. [Google Scholar] [CrossRef] [PubMed]
- Roy, B.; Kumar, V.; Venkatesh, A. Health Care Workers’ Reluctance to Take the Covid-19 Vaccine: A Consumer-Marketing Approach to Identifying and Overcoming Hesitancy. NEJM Catal. Innov. Care Deliv. 2020, 1, 1–10. [Google Scholar] [CrossRef]
- Nzaji, M.K.; Ngombe, L.K.; Mwamba, G.N.; Ndala, D.B.B.; Miema, J.M.; Lungoyo, C.L.; Mwimba, B.L.; Bene, A.C.M.; Musenga, E.M. Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo. Pragmatic Obs. Res. 2020, 11, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Kuter, B.J.; Browne, S.; Momplaisir, F.M.; Feemster, K.A.; Shen, A.K.; Green-McKenzie, J.; Faig, W.; Offit, P.A. Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia. Vaccine 2021, 39, 1693–1700. [Google Scholar] [CrossRef] [PubMed]
- Cornwall, W. Just 50% of Americans Plan to Get a COVID-19 Vaccine. Here’s Kow to Win over the Rest. Science. 2020. Available online: https://www.sciencemag.org/news/2020/06/just-50-americans-plan-get-covid-19-vaccine-here-s-how-win-over-rest (accessed on 30 June 2020).
- Ashton, J. COVID-19 and the anti-vaxxers. J. R. Soc. Med. 2021, 114, 42–43. [Google Scholar] [CrossRef]
- Geoghegan, S.; O’Callaghan, K.P.; Offit, P.A. Vaccine Safety: Myths and Misinformation. Front. Microbiol. 2020, 11, 372. [Google Scholar] [CrossRef] [Green Version]
- United Nations. UN Tackles ‘Infodemic’ of Misinformation and Cybercrime in COVID-19 Crisis. 2020. Available online: https://www.un.org/en/un-coronavirus-communications-team/un-tackling-%E2%80%98infodemic%E2%8099-misinformation-and-cybercrime-covid-19 (accessed on 31 March 2020).
- Gellin, B. Why vaccine rumours stick—And getting them unstuck. Lancet 2020, 396, 303–304. [Google Scholar] [CrossRef]
- van der Linden, S.; Roozenbeek, J.; Compton, J. Inoculating against Fake News About COVID-19. Front. Psychol. 2020, 11, 566790. [Google Scholar] [CrossRef]
- Roozenbeek, J.; Schneider, C.R.; Dryhurst, S.; Kerr, J.; Freeman, A.L.J.; Recchia, G.; van der Bles, A.M.; van der Linden, S. Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 2020, 7, 201199. [Google Scholar] [CrossRef] [PubMed]
- Mitchell, A.; Oliphant, J.B. Americans Immersed in COVID-19 News; Most Think Media Are Doing Fairly Well Covering It: Pew Research Center. 2020. Available online: https://www.journalism.org/2020/03/18/americans-immersed-in-covid-19-news-most-think-media-are-doing-fairly-well-covering-it/ (accessed on 18 March 2020).
- Freeman, D.; Waite, F.; Rosebrock, L.; Petit, A.; Causier, C.; East, A.; Jenner, L.; Teale, A.-L.; Carr, L.; Mulhall, S.; et al. Coronavirus conspiracy beliefs, mistrust, and compliance with government guidelines in England. Psychol. Med. 2020, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Uscinski, J.E.; Enders, A.M.; Klofstad, C.; Seelig, M.; Funchion, J.; Everett, C.; Wuchty, S.; Premaratne, K.; Murthi, M. Why do people believe COVID-19 conspiracy theories? Harv. Kennedy Sch. Misinf. Rev. 2020, 1, 1–12. [Google Scholar] [CrossRef]
- Smith, T.C.; Reiss, D.R. Digging the rabbit hole, COVID-19 edition: Anti-vaccine themes and the discourse around COVID-19. Microbes Infect. 2020, 22, 608–610. [Google Scholar] [CrossRef]
- Scerri, M.; Grech, V. WITHDRAWN: COVID-19, its novel vaccination and fake news—What a brew. Early Hum. Dev. 2020, 105256. [Google Scholar] [CrossRef]
- Fisher, K.A.; Bloomstone, S.J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K.M. Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults. Ann. Intern. Med. 2020, 173, 964–973. [Google Scholar] [CrossRef] [PubMed]
- Qiao, S.; Tam, C.C.; Li, X. Risk exposures, risk perceptions, negative attitudes toward general vaccination, and COVID-19 vaccine acceptance among college students in South Carolina. medRxiv 2020, 11.26.20239483. [Google Scholar] [CrossRef]
- Al-Hadidi, F.; Bsisu, I.; AlRyalat, S.A.; Al-Zu’Bi, B.; Bsisu, R.; Hamdan, M.; Kanaan, T.; Yasin, M.; Samarah, O. Association between mobile phone use and neck pain in university students: A cross-sectional study using numeric rating scale for evaluation of neck pain. PLoS ONE 2019, 14, e0217231. [Google Scholar] [CrossRef]
Characteristic | Field of Work | Total | p-Value | ||
---|---|---|---|---|---|
Medical Field (n = 287) | Non-Medical Field (n = 359) | ||||
Age (years) | 26.8 ± 8.9 | 29.2 ± 12.1 | 28.2 ± 10.8 | 0.518 | |
Gender | Male | 97 (33.8) | 72 (20.1) | 169 (26.2) | <0.001 |
Female | 190 (66.2) | 287 (79.9) | 477 (73.8) | ||
Marital status | Single | 220 (76.7) | 233 (64.9) | 453 (70.1) | 0.015 |
Married | 61 (21.3) | 114 (31.8) | 175 (27.1) | ||
Divorced | 4 (1.4) | 8 (2.2) | 12 (1.9) | ||
Widowed | 2 (0.7) | 4 (1.1) | 6 (0.9) | ||
Educational level | Elementary school | 3 (1.0) | 17 (4.7) | 20 (3.1) | <0.001 |
High school | 9 (3.1) | 46 (12.8) | 55 (8.5) | ||
Diploma | 32 (11.1) | 23 (6.4) | 55 (8.5) | ||
Bachelor | 204 (71.1) | 225 (62.7) | 429 (66.4) | ||
Masters | 26 (9.1) | 43 (12.0) | 69 (10.7) | ||
Doctor of Philosophy (PhD) | 13 (4.5) | 5 (1.4) | 18 (2.8) | ||
Income (Jordanian dinars) | 1103.2 ± 3151.6 | 943.5 ± 2764.8 | 1012.5 ± 2934.0 | 0.005 | |
Area of residence | Urban | 239 (83.3) | 287 (79.9) | 526 (81.4) | 0.279 |
Rural | 48 (16.7) | 72 (20.1) | 120 (18.6) | ||
Previous history of COVID–19 | 61 (21.3) | 72 (20.1) | 133 (20.6) | 0.708 | |
Previous COVID-19 infection among family/friends | 199 (69.3) | 250 (69.6) | 449 (69.5) | 0.934 | |
Lost someone due to COVID–19 | 79 (27.5) | 135 (37.6) | 214 (33.1) | 0.007 |
Characteristic | Field of Work | Total | p-Value | |
---|---|---|---|---|
Medical Field (n = 287) | Non-Medical Field (n = 359) | |||
Concerned regarding getting COVID-19 in the future | 147 (51.2) | 191 (53.2) | 338 (52.3) | 0.616 |
Heard about COVID-19 vaccines | 286 (99.7) | 354 (98.6) | 640 (99.1) | 0.169 |
Read a scientific article about COVID-19 vaccines | 137 (47.7) | 112 (31.2) | 249 (38.5) | <0.001 |
Believe that COVID-19 vaccines are safe | 163 (56.8) | 118 (32.9) | 281 (43.5) | <0.001 |
Believe that COVID-19 vaccines are able to protect them | 149 (51.9) | 123 (34.3) | 272 (42.1) | <0.001 |
Believe that these vaccines have been sufficiently investigated | 72 (25.1) | 85 (23.7) | 157 (24.3) | 0.678 |
The Most Trusted Vaccine According to the Latest Available Information | ||||
Oxford/AstraZeneca COVID-19 vaccine | 15 (5.2) | 26 (7.2) | 41 (6.3) | <0.001 |
Sinovac COVID-19 vaccine | 23 (8.0) | 34 (9.5) | 57 (8.8) | |
Sputnik V COVID-19 vaccine | 7 (2.4) | 16 (4.5) | 23 (3.6) | |
Moderna COVID-19 Vaccine | 13 (4.5) | 13 (3.6) | 26 (4.0) | |
Pfizer–BioNTech COVID-19 Vaccine | 149 (51.9) | 117 (32.6) | 266 (41.2) | |
I do not know/ I do not have enough information | 80 (27.9) | 153 (42.6) | 233 (36.1) | |
Concerns You Regarding Those Vaccines | ||||
1. Availability | 70 (24.4) | 61 (17.0) | 131 (20.3) | 0.02 |
2. Safety of packaging | 79 (27.5) | 81 (22.6) | 160 (24.8) | 0.146 |
3. Medical follow–up post vaccination | 143 (49.8) | 194 (54.0) | 337 (52.2) | 0.287 |
4. Effectiveness against mutated SARS–CoV–2 | 169 (58.9) | 214 (59.6) | 383 (59.3) | 0.852 |
Planning to take the vaccine once available | 132 (46.0) | 94 (26.2) | 226 (35) | <0.001 |
Will encourage others to take the vaccine | 131 (45.6) | 94 (26.2) | 225 (34.8) | <0.001 |
Took influenza vaccine in the last year | 83 (28.9) | 37 (10.3) | 120 (18.6) | <0.001 |
Took all your scheduled vaccines when you were a child | 282 (98.3) | 346 (96.4) | 628 (97.2) | 0.149 |
Consider themselves as antivaxxers | 12 (4.2) | 47 (13.1) | 59 (9.1) | <0.001 |
Characteristic | Field of Work | Total | p-Value | |
---|---|---|---|---|
Medical Field (n = 287) | Non-Medical Field (n = 359) | |||
Rumors They Received via Social Media | ||||
It is unsafe | 231 (80.5) | 273 (76) | 504 (78.0) | 0.175 |
Effect of the vaccines on genetic level | 126 (43.9) | 149 (41.5) | 275 (42.6) | 0.54 |
Causes chronic illnesses | 74 (25.8) | 87 (24.2) | 161 (24.9) | 0.651 |
May lead to infertility | 84 (29.3) | 99 (27.6) | 183 (28.3) | 0.635 |
Can affect their offspring | 57 (19.9) | 73 (20.3) | 130 (20.1) | 0.881 |
Toxic heavy metals and neurotoxic materials | 65 (22.6) | 68 (18.9) | 133 (20.6) | 0.247 |
It is a part of a secret research | 114 (39.7) | 124 (34.5) | 238 (36.8) | 0.175 |
None of the above | 34 (11.8) | 47 (13.1) | 81 (12.5) | 0.635 |
The Rumors That They Believed in | ||||
It is unsafe | 92 (32.1) | 191 (53.2) | 283 (43.8) | <0.001 |
Effect of the vaccines on genetic level | 25 (8.7) | 62 (17.3) | 87 (13.5) | 0.002 |
Causes chronic illnesses | 22 (7.7) | 38 (10.6) | 60 (9.3) | 0.204 |
May lead to infertility | 15 (5.2) | 28 (7.8) | 43 (6.7) | 0.192 |
Can affect their offspring | 24 (8.4) | 32 (8.9) | 56 (8.7) | 0.805 |
Toxic heavy metals and neurotoxic materials | 15 (5.2) | 32 (8.9) | 47 (7.3) | 0.073 |
It is a part of a secret research | 37 (12.9) | 64 (17.8) | 101 (15.6) | 0.086 |
None of the above | 163 (56.8) | 126 (35.1) | 289 (44.7) | 0.001 |
Side Effects They Heard about | ||||
local pain and swelling at site of injection | 181 (63.1) | 188 (52.4) | 369 (57.1) | 0.006 |
Fever | 210 (73.2) | 196 (54.6) | 406 (62.8) | <0.001 |
Headache | 156 (54.4) | 131 (36.5) | 287 (44.4) | <0.001 |
Fatigue | 204 (71.1) | 217 (60.4) | 421 (65.2) | 0.005 |
nausea | 89 (31.0) | 87 (24.2) | 176 (27.2) | 0.055 |
pain in the joints | 87 (30.3) | 78 (21.7) | 165 (25.5) | 0.013 |
Lymphadenopathy | 57 (19.9) | 36 (10.0) | 93 (14.4) | <0.001 |
Fascial nerve palsy | 39 (13.6) | 48 (13.4) | 87 (13.5) | 0.936 |
anaphylaxis | 105 (36.6) | 96 (26.7) | 201 (31.1) | 0.007 |
Factor | Field of Work | Total | p-Value | |
---|---|---|---|---|
Medical Field (n = 287) | Non-Medical Field (n = 359) | |||
Most Encouraging Factors for Vaccination | ||||
Social media awareness campaigns | 177 (61.7) | 178 (49.6) | 355 (55.0) | 0.002 |
Mandatory in schools, universities and workplaces | 73 (25.4) | 86 (24.0) | 159 (24.6) | 0.664 |
Mandatory for travelling | 95 (33.1) | 102 (28.4) | 197 (30.5) | 0.198 |
Vaccination campaigns | 55 (19.2) | 58 (16.2) | 113 (17.5) | 0.317 |
Doctors’ advices | 148 (51.6) | 148 (41.2) | 296 (45.8) | 0.009 |
Television and radio–based advertisements | 82 (28.6) | 75 (20.9) | 157 (24.3) | 0.024 |
National medical studies to prove their efficacy | 188 (65.5) | 199 (55.4) | 387 (59.9) | 0.009 |
National medical studies to prove their safety | 173 (60.3) | 195 (54.3) | 368 (57.0) | 0.128 |
Most Influencing Social Media Tools to Encourage Vaccination | ||||
Online awareness posters | 87 (30.3) | 100 (27.9) | 187 (28.9) | 0.494 |
Influencers sharing their pictures while taking the vaccine | 109 (38.0) | 137 (38.2) | 246 (38.1) | 0.962 |
Short scientific videos | 191 (66.6) | 199 (55.4) | 390 (60.4) | 0.004 |
Short comedy videos | 52 (18.1) | 68 (18.9) | 120 (18.6) | 0.789 |
Sharing written information and posts using unified hashtags | 46 (16.0) | 59 (16.4) | 105 (16.3) | 0.889 |
Sharing pictures using unified hashtags | 39 (13.6) | 49 (13.6) | 88 (13.6) | 0.982 |
Competitions to raise awareness | 36 (12.5) | 44 (12.3) | 80 (12.4) | 0.912 |
Sponsored advertisements by non–governmental organizations | 51 (17.8) | 64 (17.8) | 115 (17.8) | 0.985 |
Rate how much you trust the safety of these vaccines | 5.2 ± 2.6 | 4.1 ± 2.7 | 4.6 ± 2.7 | <0.001 |
Rate how much you trust the efficacy of these vaccines | 5.6 ± 2.7 | 4.1 ± 2.8 | 4.8 ± 2.8 | <0.001 |
Rate how much you trust the efficacy against mutated SARS–CoV–2 | 4.5 ± 2.5 | 3.5 ± 2.5 | 3.9 ± 2.5 | <0.001 |
Rating of the extent of social media effect on the decision to get a vaccine | 7.9 ± 2.4 | 7.6 ± 2.6 | 7.7 ± 2.5 | 0.135 |
Rating of the effect of medical personnel advice on the decision to get a vaccine | 7.1 ± 2.2 | 6.8 ± 2.5 | 6.9 ± 2.4 | 0.331 |
Rating of the effect of teachers, professors and employers’ advices on the decision to get a vaccine | 6.3 ± 2.3 | 5.9 ± 2.7 | 6.1 ± 2.5 | 0.032 |
Variable | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p-Value | OR | 95% CI | p-Value | |
Age | 1 | 0.99–1.02 | 0.904 | - | - | - |
Gender | ||||||
Male | 2.67 | 1.86–3.83 | <0.001 | 1.02 | 0.56–1.85 | 0.949 |
Female | 0.375 | 0.26–0.54 | <0.001 | 0.98 | 0.54–1.78 | 0.949 |
Marital Status ** | 0.019 | 0.175 | ||||
Married | 0.55 | 0.37–0.80 | 0.002 | 0.47 | 0.24–0.92 | 0.028 |
Divorced | 0.53 | 0.14–1.96 | 0.338 | 0.97 | 0.13–7.36 | 0.975 |
Widowed | 0.79 | 0.14–4.34 | 0.783 | 0.53 | 0.03–9.28 | 0.663 |
Field of Work | ||||||
Medical field | 2.4 | 1.73–3.34 | <0.001 | 1.35 | 0.81–2.26 | 0.251 |
Non–medical field | 0.417 | 0.30–0.58 | <0.001 | 0.74 | 0.44–1.24 | 0.251 |
Area of Residence | ||||||
Urban | 1.15 | 0.75–1.75 | 0.527 | - | - | - |
Rural | 0.527 | 0.57–1.33 | 0.527 | - | - | - |
Income | 1 | 1.00–1.00 | 0.419 | - | - | - |
Previous history of COVID-19 infection | 0.69 | 0.46–1.05 | 0.083 | - | - | - |
Previous COVID-19 infection among family/friends | 1.14 | 0.80–1.62 | 0.483 | - | - | - |
Lost someone due to COVID–19 | 1.36 | 0.97–1.91 | 0.076 | - | - | - |
Concerned regarding getting COVID-19 in the future | 1.54 | 1.11–2.14 | 0.009 | 1.82 | 1.10–3.02 | 0.02 |
Rate how much you trust the safety of these vaccines | 2.61 | 2.24–3.03 | <0.001 | 2.1 | 1.72–2.56 | <0.001 |
Rate how much you trust the efficacy of these vaccines | 2.1 | 1.87–2.36 | <0.001 | 1.34 | 1.10–1.64 | 0.003 |
Rate how much you trust the efficacy against mutated SARS–CoV–2 | 1.91 | 1.73–2.12 | <0.001 | 1.03 | 0.86–1.23 | 0.746 |
Rating of the effect of medical personnel advice on the decision to get a vaccine | 1.23 | 1.14–1.33 | <0.001 | 0.83 | 0.70–0.98 | 0.026 |
Rating of the effect of teachers, professors and employers’ advices on the decision to get a vaccine | 1.31 | 1.22–1.41 | <0.001 | 1.05 | 0.91–1.21 | 0.526 |
Rating of the extent of social media effect on the decision to get a vaccine | 1.33 | 1.22–1.45 | <0.001 | 1.21 | 1.04–1.41 | 0.012 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Aloweidi, A.; Bsisu, I.; Suleiman, A.; Abu-Halaweh, S.; Almustafa, M.; Aqel, M.; Amro, A.; Radwan, N.; Assaf, D.; Abdullah, M.Z.; et al. Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study. Int. J. Environ. Res. Public Health 2021, 18, 5111. https://doi.org/10.3390/ijerph18105111
Aloweidi A, Bsisu I, Suleiman A, Abu-Halaweh S, Almustafa M, Aqel M, Amro A, Radwan N, Assaf D, Abdullah MZ, et al. Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study. International Journal of Environmental Research and Public Health. 2021; 18(10):5111. https://doi.org/10.3390/ijerph18105111
Chicago/Turabian StyleAloweidi, Abdelkarim, Isam Bsisu, Aiman Suleiman, Sami Abu-Halaweh, Mahmoud Almustafa, Mohammad Aqel, Aous Amro, Neveen Radwan, Dima Assaf, Malak Ziyad Abdullah, and et al. 2021. "Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study" International Journal of Environmental Research and Public Health 18, no. 10: 5111. https://doi.org/10.3390/ijerph18105111
APA StyleAloweidi, A., Bsisu, I., Suleiman, A., Abu-Halaweh, S., Almustafa, M., Aqel, M., Amro, A., Radwan, N., Assaf, D., Abdullah, M. Z., Albataineh, M., Mahasneh, A., Badaineh, A., & Obeidat, H. (2021). Hesitancy towards COVID-19 Vaccines: An Analytical Cross–Sectional Study. International Journal of Environmental Research and Public Health, 18(10), 5111. https://doi.org/10.3390/ijerph18105111